Key facts
- MedModus’s last known valuation is $22.8M (Sep 2025).
- It has raised $2.0M; the latest was Later Stage VC ($880K) in Sep 2025.
- Notable investors include Enterprise Ireland, BES Management, Furthr, Merleview Capital, Nabroc Cooke.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for MedModus
- ·The full record, as it builds
Funding rounds
No funding rounds for MedModus are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About MedModus
Developer of a business intelligence platform designed to improve operational performance and quality of care in healthcare enterprises. The company's platform simplifies complex processes for efficient rostering, reduces waiting lists with predictive analytics, optimizes service capacity, and streamlines operations without the need for IT infrastructure, enabling healthcare industry clients to have access to actionable insights to deliver measurable improvements quickly.
- Sector
- Healthcare
- HQ
- Dublin, Ireland
- Founded
- 2017
- Employees
- 17
- Website
- medmodus.com/
- Ownership
- Privately Held (backing)
MedModus doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in MedModus shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on MedModus in its N-PORT filings yet. We sweep new filings monthly.